Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MEDI5083
i
Other names:
MEDI5083, MEDI 5083
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
AstraZeneca
Drug class:
CD40 agonist
Related drugs:
‹
ex-vivo autologous dendritic cells vaccine (4)
ABBV-428 (0)
ATOR-4066 (0)
CDX-1140 (0)
CP-870893 (0)
Chi Lob 7/4 (0)
GEN1042 (0)
GM.CD40L cell vaccine (0)
ISF35 (0)
MP0317 (0)
NG-350A (0)
SHR-7367 (0)
SL-172154 (0)
YH003 (0)
SEA-CD40 (0)
LVGN7409 (0)
ABBV-927 (0)
AMG994 (0)
ADC-1013 (0)
RG7876 (0)
PYX-107 (0)
ex-vivo autologous dendritic cells vaccine (4)
ABBV-428 (0)
ATOR-4066 (0)
CDX-1140 (0)
CP-870893 (0)
Chi Lob 7/4 (0)
GEN1042 (0)
GM.CD40L cell vaccine (0)
ISF35 (0)
MP0317 (0)
NG-350A (0)
SHR-7367 (0)
SL-172154 (0)
YH003 (0)
SEA-CD40 (0)
LVGN7409 (0)
ABBV-927 (0)
AMG994 (0)
ADC-1013 (0)
RG7876 (0)
PYX-107 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login